Reported results
- Third quarter 2026 revenue was $2.668980 million.
- Net income was $10.535560 million for the quarter ended September 30, 2026.
- Net income attributable to DataMeds AI was $10.589764 million for the third quarter of 2026.
- Diluted net income per common share was $2.72 for the third quarter of 2026.
- Loss from operations was $3.373956 million for the third quarter of 2026.
Notes
The Company regained full compliance with Nasdaq listing standards on October 19, 2026.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-13 (8-K, Item 2.02). Read the original filing on sec.gov.
